Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunilla Källenius

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Current Opinion in Infectious Diseases|May 3, 2005
Recent developments in tuberculosis vaccinesMelles Haile, Gunilla Källenius
Cold Spring Harbor Perspectives in Medicine|March 30, 2026
Tuberculosis and HIV Coinfection: Advances and Remaining ConcernsJudith Bruchfeld, Marianne Jansson, Gunilla Källenius
European Journal of Immunology|September 23, 2023
From simple to complex: Protein-based biomarker discovery in tuberculosisZaynab Mousavian, Gunilla Källenius, Christopher Sundling
Cold Spring Harbor Perspectives in Medicine|February 28, 2015
Tuberculosis and HIV CoinfectionJudith Bruchfeld, Margarida Correia-Neves, Gunilla Källenius
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 28, 2024
Diagnostic markers reflecting dysregulation of the host response in the transition to tuberculosis diseaseGunilla Källenius, Margarida Correia-Neves, Christopher Sundling
Human Vaccines|April 8, 2010
Towards new tuberculosis vaccinesStefan Svenson, Gunilla Källenius, Andrzej Pawlowski, et al.
Tuberculosis (Edinburgh, Scotland)|February 27, 2007
Should a new tuberculosis vaccine be administered intranasally?Gunilla Källenius, Andrzej Pawlowski, Per Brandtzaeg, et al.
Frontiers in Immunology|October 2, 2019
Lipoarabinomannan in Active and Passive Protection Against TuberculosisMargarida Correia-Neves, Christopher Sundling, Andrea Cooper, et al.
Trends in Microbiology|September 9, 2008
Mycobacterial glycoconjugates as vaccine candidates against tuberculosisGunilla Källenius, Andrzej Pawlowski, Beston Hamasur, et al.
Infection and Immunity|January 5, 2012
Failure to recruit anti-inflammatory CD103+ dendritic cells and a diminished CD4+ Foxp3+ regulatory T cell pool in mice that display excessive lung inflammation and increased susceptibility to Mycobacterium tuberculosisChaniya Leepiyasakulchai, Lech Ignatowicz, Andrzej Pawlowski, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Current Opinion in Infectious Diseases|May 3, 2005
Recent developments in tuberculosis vaccinesMelles Haile, Gunilla Källenius
Cold Spring Harbor Perspectives in Medicine|March 30, 2026
Tuberculosis and HIV Coinfection: Advances and Remaining ConcernsJudith Bruchfeld, Marianne Jansson, Gunilla Källenius
European Journal of Immunology|September 23, 2023
From simple to complex: Protein-based biomarker discovery in tuberculosisZaynab Mousavian, Gunilla Källenius, Christopher Sundling
Cold Spring Harbor Perspectives in Medicine|February 28, 2015
Tuberculosis and HIV CoinfectionJudith Bruchfeld, Margarida Correia-Neves, Gunilla Källenius
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 28, 2024
Diagnostic markers reflecting dysregulation of the host response in the transition to tuberculosis diseaseGunilla Källenius, Margarida Correia-Neves, Christopher Sundling
Human Vaccines|April 8, 2010
Towards new tuberculosis vaccinesStefan Svenson, Gunilla Källenius, Andrzej Pawlowski, et al.
Tuberculosis (Edinburgh, Scotland)|February 27, 2007
Should a new tuberculosis vaccine be administered intranasally?Gunilla Källenius, Andrzej Pawlowski, Per Brandtzaeg, et al.
Frontiers in Immunology|October 2, 2019
Lipoarabinomannan in Active and Passive Protection Against TuberculosisMargarida Correia-Neves, Christopher Sundling, Andrea Cooper, et al.
Trends in Microbiology|September 9, 2008
Mycobacterial glycoconjugates as vaccine candidates against tuberculosisGunilla Källenius, Andrzej Pawlowski, Beston Hamasur, et al.
Infection and Immunity|January 5, 2012
Failure to recruit anti-inflammatory CD103+ dendritic cells and a diminished CD4+ Foxp3+ regulatory T cell pool in mice that display excessive lung inflammation and increased susceptibility to Mycobacterium tuberculosisChaniya Leepiyasakulchai, Lech Ignatowicz, Andrzej Pawlowski, et al.
Pageof 6